Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

RNA silencing treatment

Edelweiss: Cancer Open Access journal | Cancer epigenetics Research articles | Open access nanotechnology Articles

RNA silencing treatment may vary depending on what type of cancer is being targeted, but one challenge remains in all of them: it is incredibly difficult to target without killing good cells. Cancer drugs and therapies all have very low selective toxicity. However, with the help of nanotechnology and RNA silencing, new and better treatments may be on the horizon for certain forms of cancer.
Edelweiss Publication Inc is an open access journal which aims to publish most complete and genuine source of information in the form of short commentary, mini review, case report, related, but not limited to above areas and making them available freely through online without any subscriptions and restrictions to researches worldwide

Researchers, authors, reviewers, and readers can use this page to find journal resources connected with RNA silencing treatment, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.

Related Articles

Related article links for RNA silencing treatment will appear here as matching content is published in Edelweiss: Cancer Open Access (ISSN: 2689-6737). Readers can also browse the journal archive and current issue for connected research.

More Topics in This Journal

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Subscribe for updates

Subscribe

to get latest updates.


  Life Science

  Health Science

  Chemical Science


Subscribe